Kinetic and mechanistic data needs for a human phsiologically based pharmacokinetic (PBPK) model for acrylamide

Andersen, ME; Scimeca, J; Olin, SS

HERO ID

19012

Reference Type

Journal Article

Subtype

Review

Year

2005

Language

English

PMID

16780359

HERO ID 19012
Material Type Review
In Press No
Year 2005
Title Kinetic and mechanistic data needs for a human phsiologically based pharmacokinetic (PBPK) model for acrylamide
Authors Andersen, ME; Scimeca, J; Olin, SS
Journal Advances in Experimental Medicine and Biology
Volume 561
Issue 6
Page Numbers 117-125
Abstract A pharmacokinetic (PBPK) model has been developed for acrylamide (AMD) and its oxidative metabolite, glycidamide (GLY), in the rat based on available information. Despite gaps and limitations to the database, model parameters have been estimated to provide a relatively consistent description of the kinetics of acrylamide and glycidamide using a single set of values (with minor adjustments in some cases). Future kinetic and mechanistic studies will need to focus on the collection of key data for refining certain model parameters and for model validation, as well as for conducting studies that elucidate the mechanism of action. Development of a validated human AMD/GLY PBPK model capable of predicting target tissue doses at relevant dietary AMD exposures, in combination with expanding data on modes of action, should allow for a substantive improvement in the risk assessment of acrylamide in food.
Doi 10.1021/tx050337k
Pmid 16780359
Wosid WOS:000238323200011
Is Certified Translation No
Dupe Override No
Conference Name 1st International Symposium on Chemistry and Safety of Acrylamide in Food
Conference Date MAR 29-31, 2004
Comments ECRIB.Chem. Biol. Interact. 135: 267-284.
Is Public Yes
Language Text English
Keyword 2-Chloro-1,3-butadiene; (1-Chloroethenyl)oxirane; Metabolism; Species differences
Is Qa No
Relationship(s)